Jörg Knäblein

Title: Jörg Knäblein: Innovator in Pharmaceutical Chemistry

Introduction

Jörg Knäblein is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on triazolone compounds. With a total of 2 patents, his inventions are aimed at addressing critical health issues.

Latest Patents

Jörg Knäblein's latest patents focus on 4,5-annulated 1,2,4-triazolones. The present invention provides triazolone compounds of general formula (I), in which R, R, R, R, and R are defined within the patent documentation. These patents detail methods for preparing said compounds, intermediate compounds useful for their preparation, and pharmaceutical compositions that include these compounds. The compounds are intended for the treatment or prophylaxis of diseases, particularly hyperproliferative disorders, either as a sole agent or in combination with other active ingredients.

Career Highlights

Throughout his career, Jörg Knäblein has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical chemistry.

Collaborations

Jörg has collaborated with several professionals in his field, including Stefan Nikolaus Gradl and Duy Nguyen. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jörg Knäblein is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.